-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Cogent Biosciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2017 to 2023.
- Cogent Biosciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$59M, a 33.7% decline year-over-year.
- Cogent Biosciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$227M, a 44.3% decline year-over-year.
- Cogent Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$192M, a 37.2% decline from 2022.
- Cogent Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$140M, a 94% decline from 2021.
- Cogent Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$72.3M, a 3.39% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)